poisar

News

Current market catalysts

Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.

Latest Coverage

Latest Headlines

30 headlines

  1. Globenewswire IncJames Altucher

    James Altucher: Elon Musk's Next Move Could Eclipse Everything He's Ever Built, and It May Be His Last

    Tech investor James Altucher claims Elon Musk is positioning to dominate artificial intelligence through a combination of proprietary chip manufacturing (Terafab), a merger of his AI and space companies, and end-to-end control of AI infrastructure. Altucher argues this opportunity could outsize Tesla, SpaceX, and xAI combined and represents a once-in-a-generation technological shift.

  2. The Motley FoolPatrick Sanders

    Adobe's Next Earnings Report on Sept. 10 Could Send the Stock Plunging. Here's Why.

    Adobe faces a critical earnings report on Sept. 10 as it navigates AI disruption to its core creative software business. The company has tripled AI-first revenue to $500 million annualized recurring revenue but must balance aggressive user acquisition through freemium offerings with meaningful monetization. Adobe stock is down 26% year-to-date amid competition from AI tools and rivals like Figma and Canva, while the company undergoes leadership transitions with a new CEO taking over in December.

  3. The Motley FoolNeha Chamaria

    Why SSR Mining Stock Surged 45% in August

    SSR Mining stock surged 45.3% in August after selling its troubled Çöpler mine in Turkey for $1.5 billion in June. The sale left the company with $1.8 billion in cash and no debt, enabling management to repurchase over $300 million in stock and reinstate dividends. Rising gold prices and improved operational fundamentals further boosted the stock, which hit a 52-week high of $39.44.

  4. The Motley FoolBrendan Coffey

    Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026?

    The article compares two healthcare-focused ETFs from iShares: IHE (Pharmaceuticals ETF) with 55 holdings and IYH (Healthcare ETF) with 100 holdings. While IHE delivered stronger 1-year returns of 50% versus IYH's 27.4%, the article recommends IYH as the better choice due to superior 3- and 5-year performance, greater diversification, and larger asset base of $3.9B. Both funds have identical 0.37% expense ratios.

  5. Zacks Investment ResearchZacks.Com

    Is Realty Income's 5.3% Yield Still Compelling? Buy or Hold the Stock?

    Realty Income's 5.3% dividend yield offers only a modest 50 basis point premium over the 10-year Treasury yield, raising questions about its attractiveness. With a forward P/FFO multiple of 13.45X and expected 4% AFFO growth, the stock lacks room for valuation expansion unless interest rates decline or growth accelerates. The analyst recommends a Hold rating for current shareholders while suggesting potential buyers wait for better entry points.

  6. SEC EDGARSEC EDGAR

    8-K filing — Federal Home Loan Bank of San Francisco

    Filed: 2026-09-08 AccNo: 0001316944-26-000148 Size: 158 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Source
Source-attributed market-news archive
Observed
Checked
Cadence
Continuous captured-news feed
Status
fresh